Health Ministry prohibits the manufacture, sale or distribution of 156 Fixed Dose Combinations by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Ministry of Health and Family Welfare (MoHFW) has implemented an immediate ban on 156... Read More
Health Ministry restricts the manufacture, sale or distribution of two Fixed Dose Combinations of Naproxen subject to certain conditions by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Ministry of Health and Family Welfare (“MoHFW”) has implemented restriction on the... Read More
Ministry of Health and Family Welfare prohibits the manufacture, sale, and distribution of S(+) Etodolac and Paracetamol Combination over safety concerns by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Health Ministry has prohibited the manufacture, sale, and distribution of the fixed-dose... Read More
CDSCO streamlines online application process for registration of cosmetics prior to import; restricts maximum number of products to 50 in single online application effective from 16th August, 2024 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsWith a view to streamline the online filing process for applications related to the mandatory... Read More
Public comments invited on Draft Guidelines on Good Distribution Practices for Pharmaceutical Products till 9th September, 2024 by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Central Drugs Control Standards Organization (CDSCO) has invited public comments on draft... Read More
DCGI specifies select countries for considering waiver of clinical trials for five specific categories of new drugs by Lexplosion Solution | Oct 9, 2024 | Central, OPS, PharmaceuticalsThe Drugs Controller General India (“DCGI”) has identified specific countries under the Rule 101... Read More